Skip to main content
main-content

The independent medical news service

11-01-2019 | Oncology | News | Article

Concomitant TKI–PPI use may adversely affect cancer patient survival

Taking proton pump inhibitors alongside tyrosine kinase inhibitors is associated with an increased mortality risk in older cancer patients, research indicates.

03-12-2018 | Chronic myeloid leukaemia | Video

EUTOS long-term survival score recommended over Sokal score for elderly CML patients

Presenting author Fausto Castagnetti discusses the results of their study assessing the best score to predict outcomes in older patients with chronic myeloid leukaemia (4:17).

09-04-2018 | Leukaemia | News | Article

FDA announces further approvals for nilotinib, blinatumomab

Click through for more information about these leukemia decisions

07-03-2018 | Oncology | News | Article

Dasatinib confirmed as pediatric chronic phase CML option

The tyrosine kinase inhibitor dasatinib is effective and well tolerated as a first- or second-line therapy for children with chronic myeloid leukemia in the chronic phase, research confirms.

05-01-2018 | Oncology | News | Article

Nilotinib update acknowledges discontinuation feasibility

Read more on this US FDA decision here

21-12-2017 | Oncology | News | Article

FDA approvals announced for advanced RCC, CML

Read more on these decisions here

image credits